摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-2-(1-hydroxypropan-2-yl)-5-nitroisoquinolin-1(2H)-one | 950915-26-1

中文名称
——
中文别名
——
英文名称
(R)-2-(1-hydroxypropan-2-yl)-5-nitroisoquinolin-1(2H)-one
英文别名
2-[(2R)-1-hydroxypropan-2-yl]-5-nitroisoquinolin-1-one
(R)-2-(1-hydroxypropan-2-yl)-5-nitroisoquinolin-1(2H)-one化学式
CAS
950915-26-1
化学式
C12H12N2O4
mdl
——
分子量
248.238
InChiKey
MLORHOHNTRJWCX-MRVPVSSYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    86.4
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    (R)-2-(1-hydroxypropan-2-yl)-5-nitroisoquinolin-1(2H)-one 在 palladium 10% on activated carbon 、 氢气 作用下, 以 乙酸乙酯 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 18.0h, 以99%的产率得到(R)-5-amino-2-(1-hydroxypropan-2-yl)isoquinolin-1(2H)-one
    参考文献:
    名称:
    The role of polycyclic frameworks in modulating P2X7 receptor function
    摘要:
    Herein we describe our recent attempts to target the P2X7 receptor for potential treatment of neurological disorders. This work focusses on different polycycles including carborane, adamantane or cubane, joined by either a cyanoguanidine or an amide linker to phenyl or isoquinoline moieties. We have demonstrated the superiority of the adamantyl moiety over other polycycles in terms of synthetic accessibility and biological (cellular) activity. We have also shown that an amide or cyanoguanidine linker can greatly alter the biological activity of compounds. This SAR study provides important insights into the types of functionality required to target the P2X7 receptor. (C) 2017 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2017.10.075
  • 作为产物:
    描述:
    参考文献:
    名称:
    The role of polycyclic frameworks in modulating P2X7 receptor function
    摘要:
    Herein we describe our recent attempts to target the P2X7 receptor for potential treatment of neurological disorders. This work focusses on different polycycles including carborane, adamantane or cubane, joined by either a cyanoguanidine or an amide linker to phenyl or isoquinoline moieties. We have demonstrated the superiority of the adamantyl moiety over other polycycles in terms of synthetic accessibility and biological (cellular) activity. We have also shown that an amide or cyanoguanidine linker can greatly alter the biological activity of compounds. This SAR study provides important insights into the types of functionality required to target the P2X7 receptor. (C) 2017 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2017.10.075
点击查看最新优质反应信息

文献信息

  • Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
    申请人:Kelly G. Michael
    公开号:US20070225324A1
    公开(公告)日:2007-09-27
    Bicycloheteroaryl compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    折环杂环芳基化合物的化学式如下所示: 这些化合物可以制备成药物组合物,并可用于预防和治疗包括人类在内的哺乳动物的各种疾病,例如疼痛、炎症、创伤等。
  • Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof
    申请人:Kelly Michael G.
    公开号:US20100184802A1
    公开(公告)日:2010-07-22
    Bicycloheteroaryl compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.
    本发明揭示了具有以下式子表示的Bicycloheteroaryl化合物:这些化合物可以制备成药物组合物,并可用于预防和治疗哺乳动物包括人类的各种情况,包括但不限于疼痛,炎症,创伤性损伤等。
  • BICYCLOHETEROARYL COMPOUNDS AS P2X7 MODULATORS AND USES THEREOF
    申请人:Second Genome, Inc.
    公开号:EP2124562B1
    公开(公告)日:2016-04-20
  • US7816371B2
    申请人:——
    公开号:US7816371B2
    公开(公告)日:2010-10-19
  • US8093265B2
    申请人:——
    公开号:US8093265B2
    公开(公告)日:2012-01-10
查看更多